GI Dynamics
134 articles about GI Dynamics
-
GI Dynamics Release: St. Vincent's Clinic and Macquarie University in Sydney Incorporate EndoBarrier® Therapy Into Type 2 Diabetes and Obesity Treatment Option
9/24/2012
-
GI Dynamics Gets FDA Nod for Pivotal Obesity Trial
8/23/2012
-
GI Dynamics Release: Appendix 4C Quarterly Report Quarter Ended 30 June 2012
7/30/2012
-
GI Dynamics to Hold Briefing Call and Webcast on Financial Results for Second Quarter 2012
7/23/2012
-
GI Dynamics Announces Further Strengthening of Commercial Foundation for EndoBarrier® Therapy and Progress With New Centers in Key Markets
7/17/2012
-
Data on GI Dynamics’ EndoBarrier® Therapy Presented at the American Diabetes Association 72nd Scientific Sessions
6/11/2012
-
GI Dynamics Release: EndoBarrier® Therapy to be Featured at Digestive Disease Week 2012
5/14/2012
-
GI Dynamics Release: EndoBarrier® Therapy Data Published in Annals of Surgery
5/1/2012
-
GI Dynamics Announces New Data Demonstrating Feasibility of EndoBarrier® Re-Implantation
4/27/2012
-
GI Dynamics Announces First Cases of EndoBarrier® Therapy in Australia
4/19/2012
-
GI Dynamics Expands Global Commercial Team
4/4/2012
-
GI Dynamics Designates First EndoBarrier® Center of Excellence in Australia
3/8/2012
-
GI Dynamics Announces Full-Year 2011 Financial Results
2/29/2012
-
GI Dynamics Designates National Obesity Surgery Centre as Center of Excellence in the United Kingdom
2/9/2012
-
GI Dynamics Announces Commercial Availability of the EndoBarrier® for the Treatment of Type 2 Diabetes and/or Obesity in the Netherlands
1/4/2012
-
GI Dynamics Expands Availability of the EndoBarrier® Through Two New Centers of Excellence in Germany
12/14/2011
-
GI Dynamics Appoints Mark Twyman as Its Chief Commercial Officer
11/29/2011
-
GI Dynamics to Present at Lazard Capital Markets 8th Annual Healthcare Conference
11/9/2011
-
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C's Corporate Practice Advises GI Dynamics in $80 Million IPO
9/30/2011
-
GI Dynamics Launches EndoBarrier(R) in Austria for the Treatment of Type 2 Diabetes and Obesity
9/21/2011